Heart failure patients who may need an aldosterone antagonist

Less than half of eligible heart failure patients take an aldosterone antagonist (spironolactone, eplerenone). Help close the gap for patients with systolic heart failure. Now called heart failure with reduced ejection fraction (HFrEF). Think of an angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) , beta-blocker (BB), and aldoste…